Federation Des Caisses Desjardins Du Quebec Precigen, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.21 - $1.75 $1,089 - $1,575	900 New	900 $1.31 Million
Q1 2022 Aug 14, 2024	BUY	$1.91 - $3.98 $1,719 - $3,582	900 New	900 $1.9 Million
Q2 2021 Aug 30, 2024	BUY	$6.24 - $8.22 $5,616 - $7,398	900 New	900 $5.87 Million
Q1 2020 Aug 30, 2024	BUY	$1.46 - $7.19 $1,314 - $6,471	900 New	900 $3.06 Million

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

Third Security, LLC

83.5M
Shares

$71.8 Million
73.5% of portfolio
Patient Capital Management, LLC Baltimore, MD

17.9M
Shares

$15.4 Million
0.92% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

10.9M
Shares

$9.34 Million
0.02% of portfolio
Black Rock Inc. New York, NY

10.2M
Shares

$8.81 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.33M
Shares

$7.16 Million
0.0% of portfolio

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $179M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account